SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001193125-23-228030
Filing Date
2023-09-05
Accepted
2023-09-05 06:12:10
Documents
103
Period of Report
2023-06-30

Document Format Files

Seq Description Document Type Size
1 6-K d526494d6k.htm   iXBRL 6-K 115519
2 EX-99.1 d526494dex991.htm EX-99.1 94902
3 EX-99.2 d526494dex992.htm   iXBRL EX-99.2 1385479
9 GRAPHIC g526494dsp1b.jpg GRAPHIC 3331
10 GRAPHIC g526494g0724151403768.jpg GRAPHIC 4228
11 GRAPHIC g526494g0802004912683.jpg GRAPHIC 3596
12 GRAPHIC g526494g0802011329144.jpg GRAPHIC 4228
13 GRAPHIC g526494g0802011329343.jpg GRAPHIC 1625
14 GRAPHIC g526494g0802011329454.jpg GRAPHIC 1171
15 GRAPHIC g526494g0802011329625.jpg GRAPHIC 39333
16 GRAPHIC g526494g0831210904427.jpg GRAPHIC 2869
  Complete submission text file 0001193125-23-228030.txt   7836846

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA cyad-20230630.xsd EX-101.SCH 88502
5 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE cyad-20230630_cal.xml EX-101.CAL 60427
6 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE cyad-20230630_def.xml EX-101.DEF 227935
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE cyad-20230630_lab.xml EX-101.LAB 438393
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cyad-20230630_pre.xml EX-101.PRE 366345
97 EXTRACTED XBRL INSTANCE DOCUMENT d526494d6k_htm.xml XML 1644049
Mailing Address RUE EDOUARD BELIN 12 MONT-SAINT-GUIBERT C9 1435
Business Address RUE EDOUARD BELIN 12 MONT-SAINT-GUIBERT C9 1435 32 10 394 100
Celyad Oncology SA (Filer) CIK: 0001637890 (see all company filings)

IRS No.: 000000000 | State of Incorp.: C9 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-37452 | Film No.: 231234057
SIC: 2834 Pharmaceutical Preparations